Showing results (141-150 of 404) with videos related to
Sort By:
Pageof 41
Clinical Pharmacology and Therapeutics|December 1, 1990
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteersJ C Fleishaker, H Friedman, S R Pollock, et al.Frontiers in Public Health|June 2, 2020
Active Learning and Technology Approaches for Teaching Immunology to Undergraduate StudentsSharon A Stranford, Judith A Owen, Frances Mercer, et al.Cell|April 22, 1988
Mitogen- and IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed heavy chain class switchingS Lutzker, P Rothman, R Pollock, et al.Pharmacoeconomics|March 21, 2000
Health economics in the Canadian pharmaceutical industryL Assiff, M R Pollock, P Manzi, et al.Immunology Today|October 8, 2014
The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodiesH L Agulla, R R Pollock, G Spira, et al.Clinical Practice and Cases in Emergency Medicine|May 22, 2025
Retroperitoneal Necrotizing Fasciitis Following Prolonged Physical Activity: A Case ReportJordan R Pollock, Edmundo Chantler, Bhavesh Patel, et al.The Urologic Clinics of North America|November 24, 2018
Surgery for Posterior Compartment Vaginal Prolapse: Graft Augmented RepairSunchin Kim, Grant R Pollock, Christian O Twiss, et al.The Journal of Experimental Medicine|March 1, 1988
Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodiesN C Chien, R R Pollock, C Desaymard, et al.Arthroscopy, Sports Medicine, and Rehabilitation|February 22, 2021
The Top 50 Most-Cited Shoulder Arthroscopy StudiesM Lane Moore, Jordan R Pollock, Kade S McQuivey, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1988
Identification of mutant monoclonal antibodies with increased antigen bindingR R Pollock, D L French, M L Gefter, et al.Pageof 41